- Home
- YMAB vs AOMR Comparison
YMAB vs AOMR Comparison
Compare YMAB & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- AOMR
- Stock Information
- Founded
- YMAB 2015
- AOMR 2018
- Country
- YMAB United States
- AOMR United States
- Employees
- YMAB N/A
- AOMR N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- AOMR Real Estate Investment Trusts
- Sector
- YMAB Health Care
- AOMR Real Estate
- Exchange
- YMAB Nasdaq
- AOMR Nasdaq
- Market Cap
- YMAB 218.4M
- AOMR 228.8M
- IPO Year
- YMAB 2018
- AOMR 2021
- Fundamental
- Price
- YMAB $4.04
- AOMR $9.92
- Analyst Decision
- YMAB Buy
- AOMR Strong Buy
- Analyst Count
- YMAB 11
- AOMR 6
- Target Price
- YMAB $18.73
- AOMR $11.33
- AVG Volume (30 Days)
- YMAB 204.4K
- AOMR 106.5K
- Earning Date
- YMAB 05-13-2025
- AOMR 05-05-2025
- Dividend Yield
- YMAB N/A
- AOMR 12.89%
- EPS Growth
- YMAB N/A
- AOMR N/A
- EPS
- YMAB N/A
- AOMR 1.51
- Revenue
- YMAB $87,685,000.00
- AOMR $57,147,000.00
- Revenue This Year
- YMAB N/A
- AOMR N/A
- Revenue Next Year
- YMAB $18.83
- AOMR $7.33
- P/E Ratio
- YMAB N/A
- AOMR $6.57
- Revenue Growth
- YMAB 3.38
- AOMR N/A
- 52 Week Low
- YMAB $3.84
- AOMR $7.36
- 52 Week High
- YMAB $17.47
- AOMR $13.32
- Technical
- Relative Strength Index (RSI)
- YMAB 42.87
- AOMR 68.32
- Support Level
- YMAB $4.02
- AOMR $9.40
- Resistance Level
- YMAB $4.60
- AOMR $9.90
- Average True Range (ATR)
- YMAB 0.32
- AOMR 0.34
- MACD
- YMAB -0.01
- AOMR 0.18
- Stochastic Oscillator
- YMAB 23.93
- AOMR 97.06
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.